NCT06785818Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
A Registry to Assess Long-Term Safety of Patients With B-Lymphocyte Malignancies Treated With Tisagenlecleucel in South Korea
Source: ClinicalTrials.gov · Last updated 30 Jul 2026
Brief summary (registry, in English)
This study is multicenter, primary data collection, non-interventional registry study to assess long-term safety, secondary malignancy risk, and effectiveness of tisagenlecleucel in patients with B-cell malignancies in a routine clinical practice setting in Korea.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 15 Jan 2025
- Start date
- 12 Mar 2025
- Primary completion date
- 30 Dec 2039
- Lead sponsor
- Novartis Pharmaceuticals
- Diseases
- Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma, Follicular lymphoma, Childhood cancers
- NCT number
- NCT06785818
What you commit to
- Study type: Observational
- Planned participants: 500
- From 12 Mar 2025 to the primary completion date, 30 Dec 2039
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Patients who are enrolled or will be enrolled in the Novartis long term follow-up protocol CCTL019A2205B.
Who the study is looking for
- Patients who receive tisagenlecleucel infusion in the commercial setting, treated under a managed access program or other pathway, e.g., when product was manufactured for the commercial setting but turned out to be out of specification (OOS).
- Consented to data collection.
Age in the registry: 0 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Bundang Gu | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Busan | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Gyeonggi-do | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Incheon | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Jeollanam | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Seongnam-si | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Ulsan | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.